Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy

November 2024
Vol-10, Issue-6
Paper ID: 25305
ISSN: 2395-4396
Downloads: 92
Download PDF

Abstract & Details

Research Area
pharmaceutical
Keywords
kidney transplant recipients dose tacrolimus low dose effect mutant patients
Abstract
This literature review examines the complexities of tacrolimus therapy in kidney transplantation, particularly focusing on the implications of genetic variations that influence drug metabolism. Tacrolimus, a vital calcineurin inhibitor in immunosuppressive regimens, is essential for preventing organ rejection but poses dosing challenges, especially in patients with genetic predispositions or those requiring lower doses due to adverse effects. By synthesizing current research findings, this review highlights the significance of personalized medicine approaches in optimizing tacrolimus dosing and enhancing treatment outcomes for kidney transplant recipients. It underscores the need for further investigation into the genetic factors affecting drug efficacy and safety, as well as innovative strategies to tailor therapy for this vulnerable population.

Author Information

# Name Institute / Affiliation
1 KARTAVYA CHETANKUMAR PATEL SAL INSTITUTE OF PHARMACY

How to Cite

Use the following formats to cite this article in your research.

APA Style
PATEL, KARTAVYA CHETANKUMAR (2024). Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy. International Journal of Advance Research and Innovative Ideas In Education, 10(6), 394-396.
MLA Style
PATEL, KARTAVYA CHETANKUMAR. "Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy." International Journal of Advance Research and Innovative Ideas In Education, vol. 10, no. 6, 2024, pp. 394-396.
IEEE Style
KARTAVYA CHETANKUMAR PATEL, "Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy," International Journal of Advance Research and Innovative Ideas In Education, vol. 10, no. 6, pp. 394-396, 2024.
Vancouver Style
PATEL KARTAVYA CHETANKUMAR. Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy. International Journal of Advance Research and Innovative Ideas In Education. 2024;10(6):394-396.
Harvard Style
PATEL, KARTAVYA CHETANKUMAR (2024) 'Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy', International Journal of Advance Research and Innovative Ideas In Education, 10(6), pp. 394-396.
Chicago Style
PATEL, KARTAVYA CHETANKUMAR. "Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy." International Journal of Advance Research and Innovative Ideas In Education 10, no. 6 (2024): 394-396.
Turabian Style
PATEL, KARTAVYA CHETANKUMAR. "Kidney Transplant Patients, Mutant Patients, and Low-Dose Tacrolimus Therapy." International Journal of Advance Research and Innovative Ideas In Education 10, no. 6 (2024): 394-396.

Export Citation